Immunic, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 29.58 million compared to USD 25.27 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 0.58 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | 0.00% | -1.57% | -16.67% |
May. 08 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 113M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.11% | 21.83B | |
-10.16% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024